Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
02/2006
02/01/2006CN1726925A Medication for treating milk sicknss and preparation method
02/01/2006CN1726921A Oral preparation of prostaglandin E1
02/01/2006CN1726920A Nose taking powder of prostaglandin E
02/01/2006CN1726910A Effervescence tablet of miconazole nitrate for vagina and preparation technique
02/01/2006CN1239189C Chinese medicinal composition for treating endometriosis and its preparing method
02/01/2006CN1239185C Externally applied medical lotion for treating gynecopathy and its preparing process
02/01/2006CN1239169C Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method
02/01/2006CN1239160C Hormone replacement therapy
02/01/2006CN1239154C 5-HT IA receptor subtype agonist
02/01/2006CN1239153C Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups
01/2006
01/31/2006USRE38962 Diphenyl-triazole derivatives and their use as anti-gestative immuno-suppressant and anti-tumoral agents
01/31/2006US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders
01/31/2006US6992074 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds
01/31/2006US6992073 Use of N-acetyl-D-glucosamine in the manufacture of a medicament for treating cervical erosion
01/31/2006US6991916 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders
01/31/2006US6991908 Antiobestic agents methods for screening antiobestic agents and kits comprising same
01/26/2006WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect
01/26/2006US20060020046 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
01/26/2006US20060020020 Regulators of the hedgehog pathway, compositions and uses related thereto
01/26/2006US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases
01/26/2006US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain
01/26/2006US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
01/26/2006US20060019897 Anti-angiogenic polypeptides
01/26/2006US20060018984 Intravaginal washing agent
01/26/2006CA2570960A1 Compositions and methods for treating central precocious puberty
01/25/2006EP1618730A2 Aggregate radiated power control for multi-band/multi-mode satellite radiotelephone communications systems and methods
01/25/2006EP1547611A4 Medicinal agent and method for curing prostate diseases
01/25/2006EP1267901B1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress
01/25/2006EP0914158B2 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity
01/25/2006CN1726210A Novel compounds having selective inhibiting effect at GSK3
01/25/2006CN1726023A Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
01/25/2006CN1726022A Pregabalin derivatives for the treatment of fibromyalgia and other disorders and its derivitive
01/25/2006CN1726021A Alpha2delta ligands for the treatment of sexual dysfunction
01/25/2006CN1726015A Alpha2delta ligands for different pharmaceutical uses
01/25/2006CN1724536A Benzothiophene [32-b] indole kind derivative, its preparation method and use
01/25/2006CN1724520A Indenoindole ketone kind compound, its preparation method and use
01/25/2006CN1724066A Controlled release composition and method of producing the same
01/25/2006CN1724054A Medicinal prepn. for treating hypermenorrhea, and its prepn. method
01/25/2006CN1724050A Preparation process of
01/25/2006CN1724034A Vagina effervescent tablets contg. callicarpa nudiflora, and its prepn. method
01/25/2006CN1724022A Compound traditional Chinese medicinal prepn. for preventing and treating uterus abnormal bleeding disease, and its prepn. method
01/25/2006CN1724013A Traditional Chinese medicinal prepn. for treating obstruction of qi in the chest
01/25/2006CN1723989A Extractive of kudzu, and its prepn. method and use
01/25/2006CN1723954A Dripping pills made from black-bone chicken, and its prepn. method
01/25/2006CN1723948A Prepn. method of tablets for eliminating module in breast
01/25/2006CN1723947A Traditional Chinese medicine dispersion tablets
01/25/2006CN1723942A Traditional Chinese medicinal liquid for eliminating module in breast and preparation method thereof
01/25/2006CN1723941A Gynecologic antipruritic capsule, an dits prepn. method
01/25/2006CN1723939A Traditional Chinese medicine bolus for ovulation-aid and pregancy-aid
01/25/2006CN1723938A Funing effervescent tablets for treating gynecopathy, and its prepn. method
01/25/2006CN1723899A Fibranine micro-pills, and its prepn. method
01/25/2006CN1723898A Fibranine gel, and its prepn. method
01/25/2006CN1723882A Medicine composition of sublingual application or on-cheek or in nasal-cavity
01/25/2006CN1238051C Chinese patent medicine for treating vaginal bleeding after medicinal abortion operation and its preparation method
01/25/2006CN1238045C External use adhesive plaster of Chinese traditional medicine for curing gynecopathy
01/25/2006CN1238043C Medicine for treating hyperplasia of mammary glands and its preparing process
01/25/2006CN1238030C Medicine for treating gynecopathy
01/24/2006US6989385 Pyrazole compounds useful as protein kinase inhibitors
01/24/2006US6989378 novel androgen (7 alpha ,17 beta )-7-methyl-17-[(1-oxoundecyl)oxy]estr-4en-3one); oil solubility; suitable for administration by means of injection; for male contraception
01/24/2006US6989156 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
01/24/2006CA2368431C Melanocortin receptor ligands
01/24/2006CA2187525C Quinolone derivative for treatment of urinary incontinence
01/19/2006US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists
01/19/2006US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
01/19/2006US20060014701 Novel amide derivatives as growth hormone secretagogues
01/19/2006US20060014242 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
01/19/2006US20060014180 Human phosphatase RET31, and variants thereof
01/19/2006US20060013897 Compositions for cancer therapy saponins or sapogenins
01/19/2006US20060013869 Electrospun amorphous pharmaceutical compositions
01/19/2006CA2570518A1 Tetracyclic compounds as estrogen ligands
01/18/2006EP1616565A1 Composition for relieving unpleasant symptoms accompanying change in protesterone
01/18/2006EP1616563A2 Perivascular administration of anti-angiogenic factors for treating or preventing vascular diseases
01/18/2006EP1615952A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
01/18/2006EP1615925A1 Imidazopyridine derivatives as melanocortin receptor agonists
01/18/2006EP1512016B1 Screening method and anti-tumor drug candidate obtained therefrom
01/18/2006EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity
01/18/2006EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
01/18/2006EP1404672B1 Tyrosine kinase inhibitors
01/18/2006EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
01/18/2006EP1028708A4 Topical compositions for prostaglandin e 1? delivery
01/18/2006EP0998274B1 Microdose therapy of vascular conditions by no donors
01/18/2006CN1723023A morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
01/18/2006CN1721412A 7-oxo pyridopyrimidines
01/18/2006CN1720984A Medicine for treating hysteromyoma and its preparation method
01/18/2006CN1720983A Preparation with asiabell, lotus seed pulp and licorice
01/18/2006CN1720977A Female nutritive tonic capsule
01/18/2006CN1720950A Compound drop pills of Chinese angelica and its preparation method
01/18/2006CN1720947A Dripping pills with mistletoe and Chinese angelica root and process for preparing the same
01/18/2006CN1720934A Medicine for treating prostate hyperplasia and method of preparing the same
01/18/2006CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists
01/18/2006CN1236831C Compositions for protein delivery via the pulmonary route
01/18/2006CN1236807C Externally applied medicine for treating mastopathy and its preparation
01/18/2006CN1236800C Galactic medicine and its preparation
01/18/2006CN1236763C Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
01/17/2006US6987129 Treating vaginismus, dyspareunia, interstitial cystitis, vulvodynia, vulvar vestibulitis, nonspecific urethritis, female sexual arousal orgasmic disorders or increasing vaginal lubrication, etc.
01/17/2006US6987120 Pharmaceutical compounds
01/17/2006US6987098 Health supplement
01/17/2006US6987005 Where the human SNORF33 receptor has the amino acid sequence SEQ ID NO: 6; encoded by ATCC deposited plasmids; activated by either tyramine, tryptamine, or beta -phenyl-ethylamine; vectors; cells; membranes; nervous system disorders
01/17/2006US6986891 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
01/12/2006WO2004089951A8 Imidazopyridine derivatives having an affinity for melanocortin receptors